Basic Information
Basic information for C5orf64-209-21aa
Peptide Name C5orf64-209-21aa
Genome Position chr5:61757666-61757728[+]
Species Human
Peptide Sequence MYHVCFLLQVGSYILLLPNAA
Peptide Length 21
Unique No (C5orf64-212-21aa,C5orf64-214-21aa-1,C5orf64-216-21aa-1,C5orf64-220-21aa-1,C5orf64-227-21aa-2,C5orf64-228-21aa)
Grand Average of Hydropathicity 1.2905
Relative Molecular Mass 2726.16
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000656556;C5orf64-209
Transcript Length 2362
Coding Ability 0.4069
DNA Sequence Corresponding to Peptide ATGTATCATGTTTGCTTTCTTCTGCAAGTTGGCTCATACATTTTATTATTACCTAATGCTGCG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :